RAF1 and colorectal carcinoma: To explore the effects of two RAF inhibitors, B-RAF inhibitor sorafenib, and C-RAF inhibitor GW5074, on the human CRC cell lines, HCT116 and LoVo cells, the changes in cell viability were first determined using the MTT analysis.